Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2024-09-18
2025-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PMT
Phonomotor Treatment (PMT) will be administered. This treatment improves anomia by training the sound sequences of words. This is a multimodal treatment approach that includes listening, producing, visualizing, and describing sounds and sound sequences. The participant practices the sound sequence tasks with the clinician.
Phonomotor Treatment (PMT)
Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.
PCA
Phonological Components Analysis (PCA) will be administered. This treatment improves anomia by identifying phonological features of words. A picture is presented. The participant provides features of the picture name: the first sound of the word, the final sound of the word, the number of syllables of the word, another word that starts with the same sound, and another words that rhymes with the word. The participant attempts to produce the word independently and by repeating after the clinician.
Phonological Components Analysis (PCA)
Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Phonomotor Treatment (PMT)
Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.
Phonological Components Analysis (PCA)
Anomia treatment focuses on improving word-finding abilities. This intervention targets the phonology of words to improve word-finding.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Anomia
* Sufficient auditory comprehension to follow task instructions
* Phonologic impairment
Exclusion Criteria
* Chronic medical illness that interferes with adherence to testing schedule
* Severe, uncorrected vision or hearing impairment that interferes with task completion
* Moderate-severe apraxia of speech or dysarthria that interferes with task completion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nichol Castro
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nichol Castro, PhD
Role: PRINCIPAL_INVESTIGATOR
SUNY at Buffalo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UB Audiology and Speech-Language Pathology Clinic
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00008623
Identifier Type: -
Identifier Source: org_study_id